Background: Recent studies suggest that a low antioxidant level in preterm infants may predispose them to increased oxidative stress and results in hyperbilirubinemia, whereas glucose-6-phosphate dehydrogenase (G6PD) activity was found to be higher in preterm infants than in term infants. Objectives: To evaluate (1) the oxidative effect of α-naphthol on preterm and term red blood cells, and (2) the relationship between G6PD activity and the gestational age of these infants. Methods: G6PD activities were determined in preterm and term infants by a standard diagnostic method. Whole blood samples were incubated with α-naphthol for 2 h and their pre- and post-challenged reduced glutathione (GSH) levels were quantified. Results: The mean G6PD activity in preterm infants (n = 113; 13.52 ± 0.19 U/g Hb; gestational age 30.67 ± 0.28 weeks) was significantly higher than that in term infants (n = 100; 12.36 ± 0.16 U/g Hb; gestational age 39.82 ± 0.14 weeks; p < 0.001). A significantly negative correlation was demonstrated between gestational age and G6PD activity (r = –0.34, p < 0.001). GSH levels of preterm and term subjects were similar at baseline, but were significantly decreased upon challenge with α-naphthol (p < 0.001). The percentage reduction in GSH levels was similar in the various gestational age groups. Conclusions: Our data show that G6PD activities had a negative correlation with gestational age of G6PD-normal infants. The similar response of preterm and term erythrocytes to an α-naphthol challenge indicates the manifestation of an active anti-oxidative pathway mediated by cellular GSH.

Keywords:
Glucose-6-phosphate dehydrogenase, Hyperbilirubinemia, Glutathione, reduced, Oxidative stress
This content is only available via PDF.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.